Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
Dr. Caitlin McMullen and panelists Dr. Kedar Kirtane, Dr. Sarimar Agosto Salgado, and Barb Wampler, RN, discuss new therapies and clinical trial development in head and neck and…
In this episode, Becket talks with Monique Ruberu, MD, an OB/GYN in Philadelphia, about the ethics of IVF, contraceptives, and NaPro technology. Contraceptives are not only dangerous for…
Peter Attia, MD, joins MedCram to discuss the optimization of cancer screening using various techniques, including information on timing, imaging (full body MRI, etc), and liquid biopsies. Dr…
Larry W. Moreland, MD, professor of medicine and orthopedics, Division of Rheumatology, University of Colorado School of Medicine, discusses treatment strategies for rheumatoid arthritis. Dr Moreland discusses the…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
Rajiv Agarwal, MD, BS, a renowned nephrology expert, discusses the importance of early detection and treatment of chronic kidney disease (CKD), particularly in patients with type 2 diabetes.…
Surya Seshan, MBBS, of New York-Presbyterian Hospital and Weill Cornell Medical College, discusses the basics of antiphospholipid antibody syndrome, first described by Professor Hughes in the 1980s. The…
Marianne Geleijnse, Vice President of the Dutch Health Council, discussed human health as a multidimensional concept. Dr Geleijnse along with Roel Vermeulen, Utrecht University, and Martine van der…
